Zacks Investment Management Abiomed Inc Transaction History

Zacks Investment Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$277.25 - $366.29 $176,608 - $233,326	-637 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$300.63 - $371.35 $2,104 - $2,599	-7 Reduced 1.09%	637 $229,000
Q3 2021 Nov 15, 2021	BUY	$310.19 - $376.2 $199,762 - $242,272	644 New	644 $210,000
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $727,784 - $826,326	-2,900 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $25,980 - $34,051	94 Added 3.35%	2,900 $828,000
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $23,329 - $36,872	83 Added 3.05%	2,806 $912,000
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $26,944 - $34,181	-76 Reduced 2.72%	2,723 $1.23 Million
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $778,317 - $1.25 Million	2,799 New	2,799 $1.15 Million
Q1 2018 May 14, 2018	SELL	$192.49 - $295.85 $970,534 - $1.49 Million	-5,042 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$168.78 - $199.74 $771,155 - $912,612	-4,569 Reduced 47.54%	5,042 $945,000
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $1.4 Million - $1.62 Million	9,611	9,611 $1.62 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.